The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis

  1. Daniel A. Haber1,2,7,10
  1. 1Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA;
  2. 2Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA;
  3. 3Molecular RNA Biology and Cancer, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany;
  4. 4Institute of Pathology, University Hospital Heidelberg, D-69120 Heidelberg, Germany;
  5. 5Department of Pathology, Harvard Medical School, Charlestown, Massachusetts 02129, USA;
  6. 6Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts 02141, USA;
  7. 7Department of Medicine,
  8. 8Department of Surgery, Harvard Medical School, Charlestown, Massachusetts 02129, USA
    • 9 Present address: Department of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA.

    Abstract

    Insulin-like growth factor 2 (IGF2), a developmentally regulated and maternally imprinted gene, is frequently overexpressed in pediatric cancers. Although loss of imprinting (LOI) at fetal promoters contributes to increased IGF2 in tumors, the magnitude of IGF2 expression suggests the involvement of additional regulatory mechanisms. A microRNA (miRNA) screen of primary Wilms' tumors identified specific overexpression of miR-483-5p, which is embedded within the IGF2 gene. Unexpectedly, the IGF2 mRNA itself is transcriptionally up-regulated by miR-483-5p. A nuclear pool of miR-483-5p binds directly to the 5′ untranslated region (UTR) of fetal IGF2 mRNA, enhancing the association of the RNA helicase DHX9 to the IGF2 transcript and promoting IGF2 transcription. Ectopic expression of miR-483-5p in IGF2-dependent sarcoma cells is correlated with increased tumorigenesis in vivo. Together, these observations suggest a functional positive feedback loop of an intronic miRNA on transcription of its host gene.

    Keywords

    Footnotes

    • Received June 11, 2013.
    • Accepted October 25, 2013.

    This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.

    | Table of Contents

    Life Science Alliance